A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males

Completed · Phase 2 · Has a placebo group

Conditions studied: Alopecia

In brief

This study will evaluate the safety, tolerability and efficacy of the oral administration of setipiprant tablets 1000 mg twice daily (BID) relative to placebo in 18 to 49 years old males with androgenetic alopecia (AGA).

Key facts

Study ID

NCT02781311

Run by

Allergan

People needed

169

Starts

2016-07-14

Expected to finish

2018-05-22

Last updated by the study team

2019-04-05

Who can join

Age: 18 and older, up to 49. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Participant has androgenetic alopecia (AGA)
• Participant agrees to maintain current hair care regimen, refraining from hair weaving, hair colorants or dyes and non-study hair growth products during the study.

You may not qualify if…

• History of hair loss for reasons other than AGA
• Scarring of the scalp or any condition or disease of the scalp, hair or hair shaft
• Use of products within 6 months of study start used continuously for at least 1 month that could impact hair growth
• Hair-weaving within 6 months
• Use of hair colorants or dyes within 6 months.

Where it is running

• Burke Pharmaceutical Research — Hot Springs, Arkansas, United States
• Petrus Center for Aesthetic Surgery & Hair Transplantation — Little Rock, Arkansas, United States
• Therapeutics Clinical Research — San Diego, California, United States
• Radiant Research, Inc. — Santa Rosa, California, United States
• DeNova Research — Chicago, Illinois, United States
• Heartland Research Associates, LLC — Wichita, Kansas, United States
• Michigan Center for Skin Care Research — Clinton Township, Michigan, United States
• Minnesota Clinical Study Center — Fridley, Minnesota, United States
• University of Minnesota Department of Dermatology Division of Clinical research — Minneapolis, Minnesota, United States
• Wake Forest University Health Sciences Department of Dermatology Medical Center Boulevard — Winston-Salem, North Carolina, United States
• Cleveland Clinic, Dept of Dermatology — Cleveland, Ohio, United States
• NW Dermatology and Research Center — Portland, Oregon, United States
• Oregon Medical Research Center — Portland, Oregon, United States
• Penn State Hershey Medical Center Dermatology Research Office — Hershey, Pennsylvania, United States
• Radiant Research, Inc. — Greer, South Carolina, United States
• DermResearch, Inc — Austin, Texas, United States
• Suzzane Bruce and Associates P.A., The Center for Skin Research — Katy, Texas, United States
• The Education & Research Foundation, Inc — Lynchburg, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.